⌘K

Login Start Free

Home/Filings/4/0001415889-24-027348

4//SEC Filing

Mehra Anand 4

Accession 0001415889-24-027348

CIK 0001557746other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 4:20 PM ET

Size

4.7 KB

Accession

0001415889-24-027348

Insider Transaction Report

Form 4

Period: 2024-11-19

Aclaris Therapeutics, Inc.ACRS

Director

Transactions

Purchase
Common Stock
2024-11-19$2.25/sh+666,666$1,499,999→ 710,030 total

Footnotes (1)

[F1]Represents shares of Common Stock of the Issuer acquired from the Issuer pursuant to Rule 16b-3(d).

Documents

1 file

4
form4-11202024_041101.xmlPrimary

Issuer

Aclaris Therapeutics, Inc.

CIK 0001557746

Entity typeother

Related Parties

1

filerCIK 0001590102

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 4:20 PM ET
Size: 4.7 KB

View on SEC.gov